Prevalence of human parainfluenza virus in patients with acute respiratory tract infections in Beijing, 2011–2014

Clinical characteristics of patients with HPIV infections [n (%)] Parameters No. of sample HPIV HPIV‐1 HPIV‐2 HPIV‐3 HPIV‐4 Year 2011 772 70 (9·07) 28 (40·00) 8 (11·43) 27 (38·57) 7 (10·00) 2012 850 38 (4·47) 11 (28·95) 5 (13·16) 17 (44·74) 5 (13·16) 2013 1052 37 (3·52) 2 (5·40) 15 (40·54) 8 (21·62)...

Full description

Saved in:
Bibliographic Details
Published inInfluenza and other respiratory viruses Vol. 9; no. 6; pp. 305 - 307
Main Authors Shi, Weixian, Cui, Shujuan, Gong, Cheng, Zhang, Tiegang, Yu, Xiali, Li, Aihua, Chen, Meng, Luo, Ming, Huang, Fang
Format Journal Article
LanguageEnglish
Published England John Wiley & Sons, Inc 01.11.2015
John Wiley & Sons, Ltd
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Clinical characteristics of patients with HPIV infections [n (%)] Parameters No. of sample HPIV HPIV‐1 HPIV‐2 HPIV‐3 HPIV‐4 Year 2011 772 70 (9·07) 28 (40·00) 8 (11·43) 27 (38·57) 7 (10·00) 2012 850 38 (4·47) 11 (28·95) 5 (13·16) 17 (44·74) 5 (13·16) 2013 1052 37 (3·52) 2 (5·40) 15 (40·54) 8 (21·62) 12 (32·43) 2014 1304 72 (5·52) 15 (20·83) 5 (6·94) 36 (50·00) 16 (22·22) Total 3978 217 (5·46) 56 (25·81) 33 (15·21) 88 (40·55) 40 (18·43) Gender Male 2214 125 (5·65) 34 (27·20) 19 (15·2) 57 (45·60) 15 (12·00) Female 1764 92 (5·22) 22 (23·91) 14 (15·22) 31 (33·69) 25 (27·17) Age group (Years) 0–5 753 67 (7·75) 8 (11·94) 12 (17·91) 37 (55·22) 10 (14·93) 6–15 519 21 (4·05) 5 (23·81) 4 (19·05) 7 (33·33) 5 (23·81) 16–25 615 26 (4·23) 12 (46·15) 2 (7·67) 7 (26·92) 5 (19·23) 26–59 1413 66 (4·67) 22 (33·333) 6 (9·09) 22 (33·33) 16 (24·24) ≥60 678 37 (5·46) 9 (24·32) 9 (24·32) 15 (40·54) 4 (10·81) Infection sites URTIs 2171 127 (5·85) 33 (25·98) 21 (16·54) 42 (33·07) 30 (23·62) LRTIs 1807 90 (4·98) 23 (25·56) 12 (13·33) 46 (51·11) 10 (11·11) 1Upper respiratory tract infection. 2Lower respiratory tract infection. Of the 3978 patients, 90 in 1807 with lower respiratory tract infection (4·98%) and 127 in 2171 with upper respiratory tract infection (5·85%) were HPIV positive. Other symptoms frequently encountered included cough (69·79%), expectoration (38·54%), sore throat (33·33%), sneezing (32·29%), asthenia (31·25%), headache (26·04%), normal leukocyte count (84·35%), low leukocyte count (3·12%), normal lymphocyte count (95·83%), with radiological pulmonary abnormalities (29·17%).
Bibliography:SourceType-Other Sources-1
content type line 63
ObjectType-Correspondence-1
ISSN:1750-2640
1750-2659
DOI:10.1111/irv.12336